- Comment to the ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) study2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Comment to the ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) study2007 | Faculty of Medicine in Pilsen
- Renal data output from ONTARGET, TRANCEND and ADVANCE trials2010 | First Faculty of Medicine
- Tight compensation of glycemia and vascular complications in patients2008 | Second Faculty of Medicine
- Tight compensation of glycaemia and vascular complications in patients with type 2 diabetes mellitus - ADVANCE study2008 | Second Faculty of Medicine